1. Trang chủ
  2. » Kinh Doanh - Tiếp Thị

The effectiveness of tubal flushing with different contrast media

11 3 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Nội dung

The effectiveness of tubal flushing with different contrast media on fertility outcomes a systematic review and network meta analysis Ultrasound Obstet Gynecol 2019; 54 172–181 Published online 26 Jun.

Ultrasound Obstet Gynecol 2019; 54: 172–181 Published online 26 June 2019 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/uog.20238 Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta-analysis R WANG1 , N VAN WELIE2 , J VAN RIJSWIJK2 , N P JOHNSON1,3 , R J NORMAN1,4 , K DREYER2 , V MIJATOVIC2 and B W MOL1,5 Robinson Research Institute and Adelaide Medical School, The University of Adelaide, North Adelaide, Australia; Department of Reproductive Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand; Fertility SA, Adelaide, Australia; Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash University and Monash Health, Clayton, Australia K E Y W O R D S: contrast media; Fallopian tube patency test; HSG; HyCoSy; hysterosalpingography; infertility; laparoscopy; systematic review; tubal flushing ABSTRACT Objectives To compare, in women with infertility, the effectiveness and safety of tubal flushing using oil-based contrast medium, water-based contrast medium or their combination, and no tubal flushing, and to evaluate the effectiveness of tubal flushing on fertility outcome over time Methods We performed a systematic review and network meta-analysis, searching the electronic databases MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials, and trial registries, up to 25 September 2018 We included randomized controlled trials (RCTs) comparing the following interventions with each other or with no intervention in women with infertility: tubal flushing using water-based contrast medium, tubal flushing using oil-based contrast medium or additional tubal flushing with oil-based medium following diagnostic tubal flushing with water-based medium The outcomes included clinical pregnancy, live birth, ongoing pregnancy, miscarriage, ectopic pregnancy and adverse events Results Of the 283 studies identified through the search, 14 RCTs reporting on 3852 women with infertility were included Network meta-analysis showed that tubal flushing using oil-based contrast medium was associated with higher odds of clinical pregnancy within months after randomization and more subsequent live births compared with tubal flushing using water-based medium (odds ratio (OR), 1.67 (95% CI, 1.38–2.03), moderate certainty of evidence; and OR, 2.18 (95% CI, 1.30–3.65), low certainty of evidence, respectively) and compared with no intervention (OR, 2.28 (95% CI, 1.50–3.47), moderate certainty of evidence; and OR, 2.85 (95% CI, 1.41–5.74), low certainty of evidence, respectively) These results agreed with those of the pairwise meta-analysis For clinical pregnancy within months, there was insufficient evidence of a difference between tubal flushing with water-based contrast medium and no intervention (OR, 1.36 (95% CI, 0.91–2.04), low certainty of evidence) For fertility outcomes after months, there was insufficient evidence of a difference in any comparison (low to very low certainty of evidence) Compared with tubal flushing using water-based contrast medium, the use of oil-based contrast medium was associated with higher odds of asymptomatic intravasation (OR, 5.06 (95% CI, 2.29–11.18), moderate certainty of evidence) Conclusions In women with infertility undergoing fertility workup, tubal flushing using oil-based contrast medium probably increases clinical pregnancy rates within months after randomization and may increase subsequent live-birth rates, compared with tubal flushing using water-based contrast medium and compared with no intervention Evidence on fertility outcomes beyond months is inadequate to draw firm conclusions Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd INTRODUCTION Tubal flushing was initially introduced in reproductive medicine as a diagnostic test to evaluate tubal patency It constitutes an essential part of the fertility workup Correspondence to: Dr R Wang, Robinson Research Institute, The University of Adelaide, 55 King William Road, North Adelaide, SA 5006, Australia (e-mail: r.wang@adelaide.edu.au) Accepted: February 2019 Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd SYSTEMATIC REVIEW Tubal flushing and fertility outcome and is recommended in clinical guidelines1,2 Tubal flushing has been used in several different techniques to visualize tubal patency, including hysterosalpingography (HSG), hysterosalpingo-contrast sonography (HyCoSy), hysterosalpingo-foam sonography (HyFoSy) and laparoscopy with dye testing Water-based contrast media are widely used in all these procedures while oil-based contrast media are used mainly in HSG A debate about the therapeutic effects of tubal flushing started over six decades ago3,4 Several potential mechanisms have been proposed to explain such therapeutic effects, including mechanical flushing out of the debris or mucus plugs in the Fallopian tubes5 , enhancement of ciliary activity6 and immunobiological actions on the endometrium or peritoneum7–11 In order to evaluate the effect of tubal flushing on fertility outcomes, a number of studies have compared tubal flushing using different contrast media, alone or in combination, with each other or with no treatment However, no large randomized controlled trial (RCT) has compared all these different interventions, therefore a network meta-analysis incorporating both direct and indirect evidence is required to determine the most effective contrast medium in imaging techniques Moreover, considering the mechanisms proposed so far to explain the beneficial effects of tubal flushing, it is likely that its effectiveness may not remain the same over time, and therefore it is also important to assess the trend of fertility outcomes with different contrast media over time Several meta-analyses on this topic have been published12–14 These used only direct evidence in the evidence synthesis and some evaluated water- vs oil-based contrast in HSG only12,13 , but did not consider women who did not undergo tubal flushing or women with tubal flushing undergoing non-HSG techniques Moreover, none of these meta-analyses considered fertility outcomes over time12–14 We conducted this systematic review and network meta-analysis to compare the effectiveness and safety of tubal flushing according to the use of oil-based vs water-based contrast medium vs their combination, or compared with no tubal flushing, in the outcome of women with infertility undergoing fertility workup Our secondary objective was to evaluate the effectiveness of tubal flushing on fertility outcomes over time METHODS The protocol of this systematic review was registered on PROSPERO (CRD42017059832) We reported the systematic review according to the Preferred Reporting Items for Systematic Reviews and MetaAnalysis (PRISMA) extension statement for network meta-analysis15 Information sources and search strategy We searched the electronic databases EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd 173 and MEDLINE, as well as the trial registers ClinicalTrials gov, International Clinical Trials Registry Platform and Australian New Zealand Clinical Trials Registry, using combinations of relevant free words and/or index terms (Appendix S1) The last electronic database search was conducted on 25 September 2018 The reference lists of identified publications were searched manually to identify additional relevant papers Eligibility criteria We intended to include studies in which the participants were women wishing to conceive We included RCTs comparing at least two of the following treatment or control groups: (1) no tubal flushing; (2) tubal flushing with water-based contrast medium; (3) tubal flushing with oil-based contrast medium; or (4) an additional tubal flushing procedure with oil-based contrast medium after diagnostic tubal flushing with water-based contrast medium Studies reporting on tubal flushing procedures using any imaging technique, including HSG, HyCoSy, HyFoSy or laparoscopy (or hydrolaparoscopy), were eligible for inclusion Studies comparing different types of water-based, or different types of oil-based, contrast media were excluded Quasi-RCTs were excluded No language limitation was applied Outcomes The outcomes included clinical pregnancy, live birth, ongoing pregnancy, miscarriage, ectopic pregnancy and adverse events We intended to use outcomes at the longest time of follow-up in each study for the primary analysis In order to show the trend over time, we also planned a subgroup analysis to evaluate clinical pregnancy at different follow-up timepoints (i.e at 3, 6, 9, 12 and 18 months) after randomization, if data were available All short-term outcomes related to tubal flushing, such as pelvic infection and intravasation, as well as long-term outcomes, such as birth defects, were reported on Study selection, data collection and quality assessment Two reviewers (R.W and N.v.W.) independently evaluated study eligibility, extracted the data and assessed the quality of the included studies Disagreements were solved by consensus or by discussion with a third reviewer (B.W.M.) A predesigned form was used to collect the following information: name of the first author, publication year, study population, participant characteristics, study funding, types of contrast medium evaluated, details of interventions and co-interventions, sample size and outcomes If outcome data were reported in published figures, DigitizeIt version 2.2 software (I Bormann, Braunschweig, Germany; https://www.digitizeit.de/) was used to reconstruct the data from the publications16 Risk of bias within individual studies was assessed using the Cochrane Collaboration tool17 The certainty of Ultrasound Obstet Gynecol 2019; 54: 172–181 Wang et al 174 evidence across the included studies was evaluated by considering study limitations (risk of bias), indirectness of evidence, inconsistency of results, imprecision of results and risk of publication bias, using Confidence in Network Meta-analysis (CINeMA)18 We intended to perform subgroup analyses on age, duration of infertility, cause of infertility and outcomes at different timepoints after randomization if data were available We planned a sensitivity analysis by including only studies with a low risk of bias We also performed a post-hoc sensitivity analysis by excluding participants with missing outcome data17 Statistical analysis Identification We used network plots to show available head-to-head comparisons in included RCTs and a contribution matrix to illustrate the contribution of each head-to-head comparison to the overall body of evidence19,20 We then tested global inconsistency using the design-by-treatment interaction model21 and tested local inconsistency using inconsistency plots22 When there was no significant inconsistency, we performed network meta-analyses within multivariate random-effects meta-analysis models23 as well as random-effects pairwise meta-analysis17 We used the surface under the cumulative ranking (SUCRA) to rank the treatments24 , and applied comparison-adjusted funnel plots to assess small-study effects19 STATA version 15.0 (StataCorp., College Station, TX, USA) was used to perform statistical analysis and to illustrate the graphics23 Records identified through database search (n = 410): • MEDLINE (n = 96) • EMBASE (n = 235) • CENTRAL (n = 79) RESULTS Characteristics of included studies Of the 283 studies identified through the search, 14 RCTs (16 articles) reporting on 3852 women with infertility were included25–40 (Figure 1) All studies reported on women with infertility and the detailed causes of this (including unexplained infertility) were provided in all but two studies32,34 (Table 1) Funding was reported in three studies28,29,31 Outcome data at different timepoints were extracted from the figures in seven studies by using DigitizeIt 2.2 software25,28,31,32,35,37,40 Of the 14 included RCTs, the most frequent comparison was tubal flushing using water-based vs oil-based contrast medium (n = 6)26–28,32,35,36 , followed by tubal flushing using water-based medium succeeded by oil-based contrast medium vs water-based contrast medium alone Additional records identified through other sources (n = 2) Screening Records after duplicates removed (n = 283) Records screened (n = 283) Inclusion Eligibility Records excluded (n = 256) Full-text articles assessed for eligibility (n = 27) Studies included in systematic review (n = 14 RCTs) (n = 16 articles) Full-text articles excluded (n = 11): • Duplicate study population (n = 5) • Irrelevant intervention (n = 3) • Not RCT (n = 1) • Ongoing study (n = 1) • Multiple reasons (n = 1) Studies included in network meta-analysis (n = 14 RCTs) (n = 16 articles) Figure Flowchart showing selection and inclusion of randomized controlled trials (RCTs) in systematic review and meta-analysis Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 172–181 Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Denmark Rasmussen (1991)35 Continued over Japan Ogata (1993)34 USA Letterie (1990)30 UK New Zealand Johnson (2004)29 Nugent (2002)33 Netherlands Dreyer (2017)28 Denmark Netherlands de Boer (1988)27 Lindequist (1994)32 Canada/USA Alper (1986)26 Sweden Canada Al-Fadhli (2006)25 Lindborg (2009)31 Country Study 175 131 88 Tubal factor (46%); unexplained or mild male infertility (54%) NR Unexplained infertility Unexplained or mild male infertility (77%); tubal factor (23%) NR Unexplained infertility (100%) Unexplained infertility (61%); endometriosis (39%) 398 302 34 242 334 40 158 10 12 6 6 12 Oil Water Oil No flushing Oil No flushing Oil Water Water No flushing Water HSG HSG HSG — HSG — HSG HSG Lipiodol (5–10 mL) Iotrolan (Isovist) (5–10 mL) Lipiodol (mean, 5.8 mL) — Lipiodol, volume NR — Lipiodol (5–10 mL) Iohexol, Ioxaglate or diatrizoate (5–10 mL) Laparoscopy Laparoscopic tubal testing; ethiodol (20 mL) Laparoscopy Laparoscopic tubal testing; Conray-60 (20 mL) HyCoSy Echovist (< 15 mL) — — Water + oil Lipiodol (10 mL) — Telebrix Hystero (Meglumine Ioxitalamate) (5–10 mL) HSG — HSG Water Ethiodol (10 mL) Iopamidol (10 mL) Lipiodol (5–10 mL) Oil No flushing HSG HSG HSG Oil Water Oil Reno-M-60 (diatrizoate) (10–20 mL) HSG Water Oil Water Laparoscopy Dilute solution of methylene blue dye; lipiodol Laparoscopy Dilute solution of methylene blue dye; saline (10 mL) HSG Lipiodol (10–20 mL) Method of tubal flushing Contrast medium Water + oil Sample Follow-up Intervention size (n) (months) and control Unexplained or mild 1119 male infertility (87%); tubal factor (8%); other cause (5%)* Unexplained or mild male infertility Oligo-ovulation (33%); tubal factor (29%); endometriosis (8%); unexplained or mild male infertility (30%) Unexplained infertility; endometriosis Cause of infertility Table Characteristics of 14 randomized controlled trials included in systematic review None None None None None None None None None (but four women had IVF) None None None Only hormonal therapy was used Only hormonal therapy was used According to prespecified indications: IUI (17.9%), IVF/ICSI (1.4%), ovulation induction (0.5%), laparoscopy (6.2%) or hysteroscopy (4.4%) According to prespecified indications: IUI (14.8%), IVF/ICSI (1.3%), ovulation induction (0.5%), laparoscopy (6.2%) or hysteroscopy (4.2%) None None Excision of endometriotic lesions when necessary Excision of endometriotic lesions when necessary Ovulation disorders treated with clomiphene citrate Ovulation disorders treated with clomiphene citrate Co-intervention during/after tubal flushing Tubal flushing and fertility outcome 175 Ultrasound Obstet Gynecol 2019; 54: 172–181 Wang et al Only first author of each study is given *All patients had low risk of tubal pathology †Detailed data were not available owing to incomplete reporting of baseline data ‡52.7% diatrizoate meglumine and 26.8% iodipamide meglumine HSG, hysterosalpingography; HyCoSy, hysterosalpingo-contrast sonography; ICSI, intracytoplasmic sperm injection; IUI, intrauterine insemination; IVF, in-vitro fertilization; NR, not reported; oil, oil-based contrast medium; water, water-based contrast medium None HSG Water Telebrix Hystero (10 mL) None HSG Unexplained or mild male infertility (45%); anovulation (23%); endometriosis (8%); other factor (24%) Yang (1989)38 Steiner (2003)37 USA China 109 Water + oil Telebrix Hystero (10 mL); lipiodol (5 mL) Ovulatory medication (61.5%) HSG Water Sinografin‡ (5–10 mL) Ovulatory medication (53.3%) HSG Water + oil 18 56 HSG HSG Oil Water Sinografin‡ (5–10 mL); ethiodol (10 mL) IUI (25.3%) IUI (24.8%) IUI (24.8%) Sinografin‡ (mean, 8.2 mL); ethiodol (mean, 6.0 mL) Ethiodol (mean, 8.6 mL) Sinografin‡ (mean, 9.4 mL) HSG Water + oil 12 Tubal-, male-, ovulatory-, age-, uterine-, peritoneal-, endocrine-, cervical-, immunologic- or drug-associated factor or unexplained infertility† Ovulatory dysfunction (35%); endometriosis (12%); unexplained or mild male infertility (45%); tubal factor (3%) Spring (2000)36 USA 666 Method of tubal flushing Intervention and control Follow-up (months) Sample size (n) Cause of infertility Country Study Table Continued Contrast medium Co-intervention during/after tubal flushing 176 Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd (n = 5)25,30,36–38 There were three studies comparing tubal flushing using oil-based contrast medium with no tubal flushing29,33,34 , one comparing tubal flushing using water-based followed by oil-based contrast medium with the use of oil-based contrast medium only36 , and one comparing tubal flushing with water-based contrast medium with no tubal flushing31 (Table 1) Clinical pregnancy within months was the most commonly reported outcome (n = 12) The network plots for different outcomes are presented in Figure S1 Quality of evidence of individual studies With regard to selection bias, 64% (n = 9)25,26,28–31,36–38 of included RCTs reported adequate methods of random sequence generation and 36% (n = 5)28,29,31,33,38 reported adequate methods of allocation concealment, while 7% (n = 1)37 had no concealment (Table 2) As blinding was not possible owing to the nature of the interventions, we scored the risk of performance bias as unclear in all RCTs Given that all the fertility outcomes are objective outcomes, it is unlikely that the non-blinded design would affect the outcome measurement, therefore, the risk of detection bias was low in all the included studies Five RCTs25,26,30,32,34 had a high risk of attrition bias owing to the considerable proportion of missing outcome data One RCT36 was scored at high risk of other bias because the age distribution was imbalanced in the groups The majority (> 70%) of the evidence for comparisons between tubal flushing using oil-based contrast medium vs no flushing, water-based contrast medium vs no flushing and tubal flushing with oil- vs water-based contrast medium were at low risk of bias, but the evidence for the comparisons between the combination group (water-based followed by oil-based contrast medium) and the other groups was prone to bias, as at least 25% of the evidence was at high risk of bias (Figure S2) Network consistency and contribution When considering clinical pregnancy at the longest follow-up time in each study in the analysis, we found significant global and local inconsistency (Table S1 and Figure S3) Therefore, we avoided pooling the outcomes at different timepoints21 Instead, we chose clinical pregnancy at the most commonly used timepoint (6 months) as an alternative main outcome, and presented outcomes at other timepoints in subgroup analyses After separating outcomes at different timepoints, no significant global or local inconsistency was observed (Table S1 and Figure S3) Therefore, time of outcome measurement is an important source of inconsistency in this network meta-analysis The contribution of direct evidence to the network for different outcomes is presented in Figure S4 Network and pairwise meta-analysis Clinical pregnancy Twelve RCTs reported clinical pregnancy within months in a total of 2884 women The network meta-analysis Ultrasound Obstet Gynecol 2019; 54: 172–181 Tubal flushing and fertility outcome 177 Table Risk of bias in 14 randomized controlled trials included in systematic review Study Selection bias (random sequence generation) Selection bias (allocation concealment) Performance bias (blinding of participants and personnel) Detection bias (blinding of outcome assessment) Attrition bias (incomplete outcome data) Reporting bias (selective reporting) Other bias (other sources of bias) Al-Fadhli (2006)25 Alper (1986)26 de Boer (1988)27 Dreyer (2017)28 Johnson (2004)29 Letterie (1990)30 Lindborg (2009)31 Lindequist (1994)32 Nugent (2002)33 Ogata (1993)34 Rasmussen (1991)35 Spring (2000)36 Steiner (2003)37 Yang (1989)38 Low Low Unclear Low Low Low Low Unclear Unclear Unclear Unclear Low Low Low Unclear Unclear Unclear Low Low Unclear Low Unclear Low Unclear Unclear Unclear High Low Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Low Low Low Low Low Low Low Low Low Low Low Low Low Low High High Low Low Low High Low High Low High Unclear Low Low Low Unclear Unclear Unclear Low Low Unclear Low Unclear Low Unclear Unclear Low Unclear Unclear Unclear Unclear Low Low Low Unclear Low Low Low Low Unclear High Low Unclear Only first author of each study is given (Figure 2) showed that tubal flushing with oil-based contrast medium increased the odds of clinical pregnancy within months after randomization compared with no tubal flushing (odds ratio (OR), 2.28 (95% CI, 1.50–3.47); moderate certainty of evidence), while there was insufficient evidence of a difference between tubal flushing using water-based contrast medium and no tubal flushing (OR, 1.36 (95% CI, 0.91–2.04); low certainty of evidence) This suggests that, if the 6-month clinical pregnancy rate following no tubal flushing is assumed to be 16%, the clinical pregnancy rates following tubal flushing with oil-based contrast medium and water-based contrast medium would be 30% (95% CI, 22–40%) and 21% (95% CI, 15–28%), respectively Compared with water-based contrast medium, the use of oil-based medium resulted in a higher OR for clinical pregnancy within months (OR, 1.67 (95% CI, 1.38–2.03); moderate certainty of evidence) This suggests that if the 6-month clinical pregnancy rate following tubal flushing with water-based contrast medium is assumed to be 28%, the clinical pregnancy rate following tubal flushing with oil-based contrast medium would be 39% (95% CI, 35–44%) There was very low certainty of evidence for the comparison between additional oil-based tubal flushing after water-based tubal flushing and the other interventions SUCRA values for tubal flushing with a combination of water- and oil-based contrast media, oil-based contrast medium alone, water-based contrast medium alone and no tubal flushing were 83.0%, 82.0%, 31.7% and 2.5%, respectively The findings of the pairwise meta-analyses were similar to those of the network meta-analyses for these comparisons (Figure 2) There was no evidence of the existence of small-study effects (Figure S5) Subgroup analysis of clinical pregnancy within months showed similar findings to those for clinical pregnancy within months from randomization (Figure S6) With regard to clinical pregnancy within 9, 12 and 18 months, Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Comparison Odds ratio (95% CI) Water vs none (1 RCT, 334 women) Lindborg (2009)31 1.14 (0.71, 1.84) Overall 1.14 (0.71, 1.84) 1.36 (0.91, 2.04) Oil vs none (2 RCTs, 192 women) Johnson (2004)29 3.16 (1.50, 6.63) Nugent (2002)33 11.67 (0.58, 235.92) Overall 3.40 (1.65, 6.99) 2.28 (1.50, 3.47) Both vs none (0 RCT) 2.30 (1.20, 4.41) Overall Oil vs water (5 RCTs, 2065 women) Alper (1986)26 1.23 (0.54, 2.81) De Boer (1988)27 1.49 (0.78, 2.85) Dreyer (2017)28 1.64 (1.27, 2.11) Lindequist (1994)32 1.40 (0.72, 2.70) Rasmussen (1991)35 2.11 (1.19, 3.72) Overall 1.62 (1.33, 1.98) 1.67 (1.38, 2.03) Both vs water (4 RCTs, 293 women) Al-Fadhli (2006)25 1.43 (0.58, 3.52) Letterie (1990)30 3.86 (0.67, 22.11) Steiner (2003)37 2.16 (0.73, 6.36) Yang (1989)38 1.41 (0.61, 3.22) Overall 1.69 (1.02, 2.81) 1.69 (1.02, 2.81) Both vs oil (0 RCT) Overall 1.01 (0.59, 1.74) 0.5 Favors 1st intervention Favors 2nd intervention Figure Forest plots of network and pairwise meta-analyses on clinical pregnancy within months after randomization to tubal flushing with oil-based contrast medium (oil), tubal flushing with water-based contrast medium (water), additional tubal flushing with oil-based following flushing with water-based contrast medium (both) or no tubal flushing (none) Odds ratios and 95% CIs of pairwise meta-analyses are illustrated by hollow diamonds while those of network meta-analyses are illustrated by filled diamonds Ultrasound Obstet Gynecol 2019; 54: 172–181 Wang et al 178 neither network meta-analysis nor pairwise meta-analysis showed any statistically significant differences in most comparisons As the breakdown outcome data on women of different ages or with different duration or cause of infertility were not available, no subgroup analyses on these variables were performed Sensitivity analyses of studies with an overall low risk of bias and after excluding participants with missing outcome data showed findings consistent with the main findings of the network meta-analysis for clinical pregnancy within months (Figure S7) Live birth and ongoing pregnancy with water-based contrast medium is assumed to be 22%, the live-birth rate following tubal flushing with oil-based contrast medium would be 38% (95% CI, 27–51%) SUCRA values for tubal flushing with oil-based and water-based contrast media and no tubal flushing were 99.9%, 41.1% and 9.0%, respectively The findings of the pairwise meta-analyses were consistent with those of the network meta-analyses (Figure 3) The results for ongoing pregnancy resulting from pregnancy occurring within months following intervention (four RCTs, 1645 women) were consistent with those for live birth (Figure S6) Miscarriage, ectopic pregnancy and adverse events Five studies reported on live birth resulting from pregnancy within months in a total of 2043 women The network meta-analysis (Figure 3) showed that tubal flushing using oil-based contrast medium resulted in higher odds of live birth compared with no tubal flushing (OR, 2.85 (95% CI, 1.41–5.74); low certainty of evidence), while there was insufficient evidence of a difference between tubal flushing using water-based medium and no tubal flushing (OR, 1.31 (95% CI, 0.70–2.44); low certainty of evidence) This suggests that, if the live-birth rate resulting from clinical pregnancy within months following no tubal flushing is assumed to be 16%, the live-birth rates following tubal flushing with oil-based contrast medium and water-based contrast medium would be 35% (95% CI, 21–52%) and 20% (95% CI, 12–32%), respectively Tubal flushing using oil-based contrast medium resulted in higher odds of live birth than did the use of water-based contrast medium (OR, 2.18 (95% CI, 1.30–3.65); low certainty of evidence) This suggests that, if the live-birth rate following tubal flushing Comparison Odds ratio (95% CI) Water vs none (1 RCT, 334 women) Lindborg (2009)31 1.13 (0.67, 1.91) Overall 1.13 (0.67, 1.91) There was no conclusive evidence of a difference in any of the comparisons for miscarriage or ectopic pregnancy (Figure S6) Five studies reported no short-term adverse events following tubal flushing Pooled analysis of the three studies that reported on intravasation showed that, compared with water-based contrast medium, oil-based contrast medium was associated with higher odds of asymptomatic intravasation (OR, 5.06 (95% CI, 2.29–11.18); three studies; I2 = 0) No cases of pulmonary embolism or death were reported Three studies reported on pelvic infection, of which two compared tubal flushing with water-based vs oil-based contrast medium Pooled analysis showed that there was insufficient evidence of differences in the incidence of pelvic infection between these two interventions (OR, 0.23 (95% CI, 0.04–1.27); two studies; I2 = 0) (Figure S6) Only one study28 reported long-term adverse events, in which three newborns in the group of women who underwent tubal flushing with oil-based contrast medium had skeletal dysplasia, esophageal atresia and chromosomal mosaicism, respectively No congenital abnormalities were seen in neonates born to women who underwent tubal flushing with water-based medium 1.31 (0.70, 2.44) Oil vs none (2 RCTs, 192 women) DISCUSSION Johnson (2004)29 3.09 (1.39, 6.91) Nugent (2002)33 11.67 (0.58, 235.92) Overall 3.38 (1.56, 7.34) Summary of key findings Figure Forest plots of network and pairwise meta-analyses on live birth resulting from pregnancy within months after randomization to tubal flushing with oil-based contrast medium (oil), tubal flushing with water-based contrast medium (water) or no tubal flushing (none) Odds ratios and 95% CIs of pairwise meta-analyses are illustrated by hollow diamonds while those of network meta-analyses are illustrated by filled diamonds For the comparisons between tubal flushing using oil-based contrast medium vs water-based contrast medium or no tubal flushing, the overall certainty of evidence was moderate for short-term clinical pregnancy, low for short-term live birth and low to very low for outcomes beyond months Tubal flushing using oil-based contrast medium probably increases short-term (6 months) clinical pregnancy rate, and may increase subsequent live-birth rate compared with tubal flushing with water-based contrast medium and no tubal flushing, but it is not certain whether this effect persists beyond months The evidence on the effectiveness of tubal flushing using water-based contrast medium compared with no tubal flushing was insufficient (low certainty of evidence) Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 172–181 2.85 (1.41, 5.74) Oil vs water (2 RCTs, 1517 women) Dreyer (2017)28 1.64 (1.27, 2.11) Rasmussen (1991)35 3.14 (1.66, 5.94) Overall 2.12 (1.14, 3.94) 2.18 (1.30, 3.65) 0.5 Favors 1st intervention Favors 2nd intervention Tubal flushing and fertility outcome Strengths and limitations The strengths of this systematic review include that it incorporates evidence from both direct and indirect comparisons, provides a hierarchy of rankings of effectiveness and uses multiple approaches for sensitivity analysis Moreover, time from randomization was incorporated into the outcome assessments and was identified as a source of inconsistency Our current outcome-reporting strategy not only reduced the heterogeneity in outcome reporting across trials but also illustrated the trend of effectiveness of different interventions over time On the other hand, several limitations of our meta-analysis should be addressed Firstly, not all trials reported live birth Despite this, the agreement between the results for live birth and those for clinical pregnancy provided some reassurance for our main conclusion Secondly, although the majority of the participants were broadly defined as having unexplained infertility, including endometriosis and mild male-factor infertility, the study population also included other causes of infertility; the heterogeneous nature of the study population may have resulted in selection bias Thirdly, some of the studies had a high risk of selection, attrition or other bias This resulted in an overall low quality of evidence in some comparisons, especially in the combination group of tubal flushing with oil-based medium following flushing with water-based contrast medium Finally, the association between available evidence and competing interests of the manufacturer was unclear in most studies Only three studies28,29,36 reported funding sources and all were from academic institutes or societies, including one29 with additional support from industry Clinical implications The effect of tubal flushing using oil-based contrast medium has not been evaluated outside HSG HyCoSy is an accurate test for diagnosing tubal occlusion and performs similarly to HSG41 It prevents women from being exposed to radiation and, therefore, has replaced HSG in fertility workup in many settings More recently, HyFoSy has become commonly used, and a trial on its diagnostic accuracy and cost-effectiveness in fertility workup is underway42 The costs of HyCoSy with sonographic contrast and HSG with water-based contrast are considered similar43 , while HyFoSy may further reduce the cost42 In HSG, oil-based contrast is more expensive than is water-based contrast, with an extra US$ 8198 for an additional ongoing pregnancy in ovulatory women with infertility at low risk for tubal pathology44 Cost-effectiveness should also be considered in shared decision-making Several safety concerns regarding tubal flushing have been raised Firstly, venous intravasation occurs in approximately 2–7% of cases undergoing HSG45–47 and seems to occur more frequently when using oil-based contrast medium Some reports on venous intravasation during ultrasound show a higher incidence (13%)48 While Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd 179 intravasation can potentially result in life-threating pulmonary embolism, we are unaware of any deaths reported since the 1960s49 This may be owing to fluoroscopy screening or the reduced use of HSG with oil-based contrast worldwide as HyCoSy and HyFoSy become more popular Secondly, any concerns about the thyroid function of mother and child are based on the effects of iodinated contrast medium50,51 and a longer-persisting time of oil-based contrast in the pelvis52 Maternal hypothyroidism can occur after tubal flushing with oil-based contrast51 , especially in women with subclinical hypothyroidism before HSG53 With regard to neonatal safety, a Japanese cohort showed that infants born to mothers undergoing HSG using oil-based contrast before conceiving had a higher incidence of thyroid dysfunction (2.4%) than did the unselected population (0.7%)50 Although there is limited evidence on these safety issues, they should be fully discussed during clinical consultations Research implications Future trials should evaluate long-term fertility outcomes after tubal flushing The effectiveness needs to be tested in trials addressing different populations, including women with advanced age, anovulation or tubal-factor infertility Safety data on women and their offspring are also needed to address the short- and long-term safety concerns The therapeutic effects of contrast media should also be tested in techniques other than HSG, such as HyCoSy, HyFoSy and hydrolaparoscopy as well as laparoscopy, for instance by using tubal flushing with oilbased contrast medium after confirming tubal patency with HyCoSy, or performing preovulatory tubal flushing without any imaging after confirmed tubal patency, followed by intrauterine insemination or timed intercourse, as suggested in some studies54,55 This would be an interesting alternative treatment for in-vitro fertilization in women with unexplained infertility The mechanical effects of flushing on the Fallopian tubes seem to be the most reasonable theory to account for its therapeutic effects, as they persist after several menstrual cycles post tubal flushing, and such effects have been observed following the use of both oil-based and water-based contrast in a recent cohort study56 With regard to the difference between different contrast media, we hypothesize that for tubes with mucus plugs or debris, the higher viscosity of the oil-based contrast causes a better flushing effect, maybe owing to a higher pressure during the tubal flushing procedure A recent study found that the treatment effect of oil-based, as compared with water-based, contrast medium was higher in women suffering from severe pain during tubal flushing57 , possibly because the higher intrauterine pressure associated with the dislodgement of mucus plugs and debris might cause more pain However, we acknowledge that such a hypothesis is difficult to test in animal models or humans Hypotheses related to other mechanisms, including the effects on Ultrasound Obstet Gynecol 2019; 54: 172–181 180 endometrial receptivity, should be further tested in future research Conclusions In women with infertility undergoing fertility workup, tubal flushing using oil-based contrast medium probably increases clinical pregnancy rates within months and may increase subsequent live-birth rates, compared to tubal flushing with water-based contrast medium or no intervention Available evidence on fertility outcomes beyond months is inadequate to draw firm conclusions ACKNOWLEDGMENTS We thank Mr Michael Draper from Barr Smith Library, University of Adelaide for his assistance in developing the search strategies This study was partly supported by an Australian Government Research Training Program (RTP) Scholarship The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript REFERENCES National Institute for Health and Care Excellence (NICE) Fertility problems: assessment and treatment NICE guideline CG156 NICE: London, UK, 2013 Practice Committee of the American Society for Reproductive Medicine Diagnostic evaluation of the infertile female: a committee opinion Fertil Steril 2015; 103: e44–50 King EL, Herring JS Sterility studies in private practice Am J Obstet Gynecol 1949; 58: 258–266 Weir WC, Weir DR Therapeutic value of salpingograms in infertility Fertil Steril 1951; 2: 514–522 Gillespie HW The Therapeutic Aspect of Hysterosalpingography Br J Radiol 1965; 38: 301–302 Soules MR, Spadoni LR Oil versus aqueous media for hysterosalpingography: a continuing debate based on many opinions and few facts Fertil Steril 1982; 38: 1–11 Sawatari Y, Horii T, Hoshiai H Oily contrast medium as a therapeutic agent for infertility because of mild endometriosis Fertil Steril 1993; 59: 907–911 Mikulska D, Kurzawa R, Rozewicka L Morphology of in vitro sperm phagocytosis by rat peritoneal macrophages under influence of oily contrast medium (Lipiodol) Acta Eur Fertil 1994; 25: 203–206 Yun AJ, Lee PY Enhanced fertility after diagnostic hysterosalpingography using oil-based contrast agents may be attributable to immunomodulation AJR Am J Roentgenol 2004; 183: 1725–1727 10 Johnson NP Review of lipiodol treatment for infertility – an innovative treatment for endometriosis-related infertility? Aust N Z J Obstet Gynaecol 2014; 54: 9–12 11 Izumi G, Koga K, Takamura M, Bo W, Nagai M, Miyashita M, Harada M, Hirata T, Hirota Y, Yoshino O, Fujii T, Osuga Y Oil-Soluble Contrast Medium (OSCM) for Hysterosalpingography Modulates Dendritic Cell and Regulatory T Cell Profiles in the Peritoneal Cavity: A Possible Mechanism by Which OSCM Enhances Fertility J Immunol 2017; 198: 4277–4284 12 Watson A, Vandekerckhove P, Lilford R, Vail A, Brosens I, Hughes E A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result? Fertil Steril 1994; 61: 470–477 13 Mohiyiddeen L, Hardiman A, Fitzgerald C, Hughes E, Mol BW, Johnson N, Watson A Tubal flushing for subfertility Cochrane Database Syst Rev 2015; 5: CD003718 14 Fang F, Bai Y, Zhang Y, Faramand A Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials Fertil Steril 2018; 110: 153–160.e3 15 Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catala-Lopez F et al The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations Ann Intern Med 2015; 162: 777–784 16 Guyot P, Ades AE, Ouwens MJ, Welton NJ Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan–Meier survival curves BMC Med Res Methodol 2012; 12: 17 Higgins JPT, Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011 The Cochrane Collaboration Available from: www.handbook cochrane.org Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Wang et al 18 Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP Evaluating the quality of evidence from a network meta-analysis PLoS One 2014; 9: e99682 19 Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G Graphical tools for network meta-analysis in STATA PLoS One 2013; 8: e76654 20 Chaimani A, Salanti G Visualizing assumptions and results in network meta-analysis: The network graphs package Stata J 2015; 15: 905–950 21 Higgins JP, Jackson D, Barrett JK, Lu G, Ades AE, White IR Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies Res Synth Methods 2012; 3: 98–110 22 Dias S, Welton NJ, Caldwell DM, Ades AE Checking consistency in mixed treatment comparison meta-analysis Stat Med 2010; 29: 932–944 23 White IR Network meta-analysis Stata J 2015; 15: 951–985 24 Salanti G, Ades AE, Ioannidis JP Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial J Clin Epidemiol 2011; 64: 163–171 25 Al-Fadhli R, Sylvestre C, Buckett W, Tulandi T A randomized study of laparoscopic chromopertubation with lipiodol versus saline in infertile women Fertil Steril 2006; 85: 505–507 26 Alper MM, Garner PR, Spence JE, Quarrington AM Pregnancy rates after hysterosalpingography with oil- and water-soluble contrast media Obstet Gynecol 1986; 68: 6–9 27 de Boer AD, Vemer HM, Willemsen WN, Sanders FB Oil or aqueous contrast media for hysterosalpingography: a prospective, randomized, clinical study Eur J Obstet Gynecol Reprod Biol 1988; 28: 65–68 28 Dreyer K, van Rijswijk J, Mijatovic V, Goddijn M, Verhoeve HR, van Rooij IAJ, Hoek A, Bourdrez P, Nap AW, Rijnsaardt-Lukassen HGM, Timmerman CCM, Kaplan M et al Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women N Engl J Med 2017; 376: 2043–2052 29 Johnson NP, Farquhar CM, Hadden WE, Suckling J, Yu Y, Sadler L The FLUSH trial – flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: a randomized trial Hum Reprod 2004; 19: 2043–2051 30 Letterie GS, Rose GS Pregnancy rates after the use of oil-based and water-based contrast media to evaluate tubal patency South Med J 1990; 83: 1402–1403 31 Lindborg L, Thorburn J, Bergh C, Strandell A Influence of HyCoSy on spontaneous pregnancy: a randomized controlled trial Hum Reprod 2009; 24: 1075–1079 32 Lindequist S, Rasmussen F, Larsen C Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography Radiology 1994; 191: 513–517 33 Nugent D, Watson AJ, Killick SR, Balen AH, Rutherford AJ A randomized controlled trial of tubal flushing with lipiodol for unexplained infertility Fertil Steril 2002; 77: 173–175 34 Ogata R, Nakamura G, Uchiumi Y, Yokoyama M, Watanabe Y, Nozaki M, Sano M, Nakano H Therapeutic efficacy of hysterosalpingography (HSG) in infertility, a prospective, randomized, clinical study Jpn J Fertil Steril 1993; 38: 91–94 35 Rasmussen F, Lindequist S, Larsen C, Justesen P Therapeutic effect of hysterosalpingography: oil- versus water-soluble contrast media – a randomized prospective study Radiology 1991; 179: 75–78 36 Spring DB, Barkan HE, Pruyn SC Potential therapeutic effects of contrast materials in hysterosalpingography: a prospective randomized clinical trial Kaiser Permanente Infertility Work Group Radiology 2000; 214: 53–57 37 Steiner AZ, Meyer WR, Clark RL, Hartmann KE Oil-soluble contrast during hysterosalpingography in women with proven tubal patency Obstet Gynecol 2003; 101: 109–113 38 Yang KN, Yeh NG, Pan SB The therapeutic effects of oil-soluble hysterosalpingography contrast medium following water-soluble hysterosalpingography contrast medium Zhonghua Yi Xue Za Zhi (Taipei) 1989; 44: 293–297 39 Lindequist S, Justesen P, Larsen C, Rasmussen F Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media – a randomized prospective study Radiology 1991; 179: 69–74 40 Johnson NP, Kwok R, Stewart AW, Saththianathan M, Hadden WE, Chamley LW Lipiodol fertility enhancement: two-year follow-up of a randomized trial suggests a transient benefit in endometriosis, but a sustained benefit in unexplained infertility Hum Reprod 2007; 22: 2857–2862 41 Maheux-Lacroix S, Boutin A, Moore L, Bergeron ME, Bujold E, Laberge P, Lemyre M, Dodin S Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis Hum Reprod 2014; 29: 953–963 42 van Rijswijk J, van Welie N, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, Kleiman-Broeze KA, Traas MAF, Muijsers G, Manger AP, Gianotten J et al The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial BMC Womens Health 2018; 18: 64 43 Lim CP, Hasafa Z, Bhattacharya S, Maheshwari A Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertility in the modern subfertility workup? Hum Reprod 2011; 26: 967–971 44 van Rijswijk J, Pham CT, Dreyer K, Verhoeve HR, Hoek A, de Bruin JP, Nap AW, Wang R, Lambalk CB, Hompes PGA, Mijatovic V, Karnon JD, Mol BW Oil-based or water-based contrast for hysterosalpingography in infertile women: a cost-effective analysis of a randomized controlled trial Fertil Steril 2018; 110: 754–760 45 Bateman BG, Nunley WC Jr, Kitchin JD 3rd Intravasation during hysterosalpingography using oil-base contrast media Fertil Steril 1980; 34: 439–443 46 Dusak A, Soydinc HE, Onder H, Ekinci F, Goruk NY, Hamidi C, Bilici A Venous intravasation as a complication and potential pitfall during hysterosalpingography: re-emerging study with a novel classification J Clin Imaging Sci 2013; 3: 67 Ultrasound Obstet Gynecol 2019; 54: 172–181 Tubal flushing and fertility outcome 181 47 Nunley WC Jr, Bateman BG, Kitchin JD 3rd, Pope TL Jr Intravasation during hysterosalpingography using oil-base contrast medium – a second look Obstet Gynecol 1987; 70: 309–312 48 Wang W, Zhou Q, Zhou X, Chen Z, Zhang H Influence Factors on Contrast Agent Venous Intravasation During Transvaginal 4-Dimensional Hysterosalpingo-Contrast Sonography J Ultrasound Med 2018; 37: 2379–2385 49 Siegler AM Dangers of hysterosalpingography Obstet Gynecol Surv 1967; 22: 284–308 50 Satoh M, Aso K, Katagiri Y Thyroid Dysfunction in Neonates Born to Mothers Who Have Undergone Hysterosalpingography Involving an Oil-Soluble Iodinated Contrast Medium Horm Res Paediatr 2015; 84: 370–375 51 So S, Yamaguchi W, Tajima H, Nakayama T, Tamura N, Kanayama N, Tawara F The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function Gynecol Endocrinol 2017; 33: 682–685 52 Miyamoto Y, Tsujimoto T, Iwai K, Ishida K, Uchimoto R, Miyazawa T, Azuma H Safety and pharmacokinetics of iotrolan in hysterosalpingography Retention and irritability compared with Lipiodol Invest Radiol 1995; 30: 538–543 53 Mekaru K, Kamiyama S, Masamoto H, Sakumoto K, Aoki Y Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium Gynecol Endocrinol 2008; 24: 498–501 ¨ ˚ 54 Edelstam G, Sjosten A, Bjuresten K, Ek I, Wanggren K, Spira J A new rapid and effective method for treatment of unexplained infertility Hum Reprod 2008; 23: 852–856 55 Maheux-Lacroix S, Dodin S, Moore L, Bujold E, Lefebvre J, Bergeron ME Preovulatory uterine flushing with saline as a treatment for unexplained infertility: a randomised controlled trial protocol BMJ Open 2016; 6: e009897 56 Dreyer K, van Eekelen R, Tjon-Kon-Fat RI, van der Steeg JW, Steures P, Eijkemans M, van der Veen F, Hompes P, Mol B, van Geloven N The therapeutic effect of hysterosalpingography in couples with unexplained subfertility: a post-hoc analysis of a prospective multi-centre cohort study Reprod Biomed Online 2019; 38: 233–239 57 van Welie N, Dreyer K, van Rijswijk J, Verhoeve HR, Goddijn M, Nap AW, Smeenk JM, Traas MA, Lambalk CB, Hompes P, Mijatovic V, Mol BW Treatment effect of oil-based contrast at HSG is dependent on pain at HSG but not on volume of contrast Fertil Steril 2018; 110: e40 SUPPORTING INFORMATION ON THE INTERNET The following supporting information may be found in the online version of this article: Appendix S1 Search strategies Table S1 Results of global inconsistency assessment Figure S1 Network plots for clinical pregnancy within months (a), months (b), months (c) and 12 months (d), and live birth resulting from pregnancy within months (e), after randomization Figure S2 Risk of bias contributions Figure S3 Inconsistency plots for clinical pregnancy at the longest follow-up time (a), clinical pregnancy within months (b), months (c) and 12 months (d), and live birth resulting from pregnancy within months (e), after randomization Figure S4 Contribution plots for clinical pregnancy within months (a), months (b), months (c) and 12 months (d), live birth resulting from pregnancy within months (e) and miscarriage within months (f) after randomization Figure S5 Comparison-adjusted funnel plots for clinical pregnancy within months (a) and months (b) after randomization Figure S6 Network and pairwise meta-analyses for clinical pregnancy at different timepoints (a), live birth at different timepoints (b), ongoing pregnancy resulting from pregnancy within months after randomization (c), miscarriage (d) and ectopic pregnancy and adverse events (e) Figure S7 Sensitivity analysis for clinical pregnancy within months when including only studies with low risk of bias (a) and when excluding participants with missing outcome data (b) A video abstract of this article is available online Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 172–181 Ultrasound Obstet Gynecol 2019; 54: 172–181 Published online 26 June 2019 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/uog.20238 Eficacia sobre el resultado de fertilidad del lavado de trompas diferentes medios de contraste: ´ sistem atica ´ ´ revisi on y metaan alisis en red RESUMEN Objetivos Comparar, en mujeres infertilidad, la efectividad y seguridad del lavado de trompas un medio de contraste a base de aceite, ´ y el no lavado de trompas, y evaluar la efectividad del lavado de trompas en el resultado un medio de contraste a base de agua o una combinacion, de la fertilidad el tiempo ´ sistematica ´ ´ ´ ´ M´etodos Se realizo´ una revision y un metaanalisis en red, mediante busquedas en las bases de datos electronicas MEDLINE, EMBASE y el Registro Central Cochrane de Ensayos Controlados, y en otros registros de ensayos, hasta el 25 de septiembre de 2018 Se ´ en mujeres incluyeron ensayos controlados aleatorizados (ECA) que compararon las siguientes intervenciones entre s´ı o la no intervencion infertilidad: lavado de trompas medio de contraste a base de agua, lavado de trompas medio de contraste a base de aceite o lavado de trompas adicional un medio a base de aceite despu´es de un lavado de trompas un medio a base de agua Los resultados incluyeron ´ ´ ´ el embarazo confirmado ecograficamente, el nacimiento vivo, el embarazo en curso, el aborto espontaneo, el embarazo ectopico y los eventos adversos ´ Resultados De los 283 estudios identificados mediante la busqueda, se incluyeron 14 ECA que informaron sobre 3852 mujeres infertilidad ´ El metaanalisis en red mostro´ que el lavado de trompas medio de contraste a base de aceite se asocio´ mayores probabilidades de embarazo ´ ´ y mas ´ nacimientos vivos posteriores en comparacion ´ el confirmado ecograficamente dentro de los seis meses posteriores a la aleatorizacion ´ de momios [RM], 1,67; IC 95%: 1,38–2,03), certeza moderada de evidencia; y RM, 2,18 (IC lavado de trompas medio a base de agua (razon ´ la no intervencion ´ (RM, 2,28 (IC 95%: 1,50–3,47), certeza 95%: 1,30–3,65), certeza baja de evidencia, respectivamente) y en comparacion moderada de evidencia; y RM, 2,85 (IC 95%: 1,41–5,74), certeza baja de evidencia, respectivamente) Estos resultados coincidieron los del ´ metaanalisis por pares No hubo evidencia suficiente de una diferencia entre el lavado de trompas medio de contraste a base de agua y la no ´ para el embarazo cl´ınico dentro de los seis meses (RM, 1,36 (IC 95%: 0,91–2,04); certeza baja de evidencia) Para los resultados de intervencion ´ (certeza de evidencia baja a muy baja) fertilidad despu´es de los seis meses, no hubo evidencia suficiente de diferencias en cualquier comparacion ´ el lavado de trompas un medio de contraste a base de agua, el uso de un medio de contraste a base de aceite se asocio´ En comparacion ´ asintomatica ´ mayores probabilidades de intravasacion (RM, 5,06 (IC 95%: 2,29–11,18), certeza moderada de evidencia) Conclusiones En las mujeres infertilidad que se someten a un examen de fertilidad, el lavado de trompas medio de contraste a base de ´ y puede aumentar las tasas aceite aumenta la probabilidad de las tasas de embarazo cl´ınico dentro de los meses posteriores a la aleatorizacion ´ el lavado de trompas medio de contraste a base de agua y en comparacion ´ la no posteriores de nacimientos vivos, en comparacion ´ La evidencia sobre los resultados de fertilidad despu´es de los seis meses es inadecuada para establecer conclusiones firmes intervencion Copyright © 2019 ISUOG Published by John Wiley & Sons Ltd SYSTEMATIC REVIEW ... compare the effectiveness and safety of tubal flushing according to the use of oil-based vs water-based contrast medium vs their combination, or compared with no tubal flushing, in the outcome of. .. oil-based tubal flushing after water-based tubal flushing and the other interventions SUCRA values for tubal flushing with a combination of water- and oil-based contrast media, oil-based contrast. .. water-based contrast medium; (3) tubal flushing with oil-based contrast medium; or (4) an additional tubal flushing procedure with oil-based contrast medium after diagnostic tubal flushing with water-based

Ngày đăng: 21/10/2022, 06:53

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN